ATR: Growth is driven by pharma innovation, strong margins, and a patient-focused, technology-led strategy
Leadership is focused on 2026 commitments and long-term growth, with pharma as the main engine. The business leverages a differentiated technology platform, drives drug delivery innovation, and maintains strong margins. Capital allocation prioritizes growth, shareholder returns, and future nose-to…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.